Excellent information about EAPH.
!!EVAN KARRAS HAS DONE A GREAT JOB AND IS SET TO ROLL EAPH WITH SIGNIFICANT ANNOUNCEMENTS. !! HERE ARE THE COLD HARD FACTS OF EAPH. IT CAN BE CHECKED BY READING THEIR FINANCIAL STATEMENTS AND EMAILING THE COMPANY it's now too late as no one will be able to stop what has been set in motion and what is going to happen with the company and its business. Easton has advanced funds for LEGITIMATE acquisitions that are soon going to generate millions of dollars in profits on top of advancing funds towards licensing. CONTRACTS ALREADY ANNOUNCED Gedeon Richter did sign an agreement with Easton / EAPH and is selling product on behalf of themselves and Easton/BMV. ( 2 Products) They have 11,000 employees and have billions in revenues so I would say that they are a pretty good partner. Congratulations to Windsor pharmaceuticals as they just spent a whole year getting regulatory approval for those products for Central America with 55,000,000 people and were now successful. Product is going to be delivered in the next few weeks and they will be selling very shortly. Let's just focus on facts . Easton has not had any shares issued in over 2 years. That means ZERO DILUTION ! Easton has raised $1.7 million through private investors which represents an acceptance of Easton's business. This is all done with ZERO DILUTION! As Easton stated, ALLIANCE / EASTON HAS CONTRACTS IN PLACE FOR THEIR AGGREGATE BUSINESS. ITS GUARANTEED REVENUES FOR EASTON. EASTON HAS THE OPTION TO GO INTO MMJ OR AGGREGATE . THE STOCK IS WAY UNDERVALUED COMPARED TO MANY OTHERS BASED ON FUTURE REVENUES I predict that Your going to soon get another big run up starting with the Bayer announcement . I predict that Very shortly big money will again be flowing into EAPH making EAPH the big play once again except this time it will have sustained new highs based on value and forward sales . New highs will be broken on its way to $.20 cents or higher. Let's look at some things Easton currently has: •. $400K in sales in the last quarter from its distribution partners Gedeon Richter who by the way have 11,000 employees and billions in revenues. •. Sales will now be starting in Central America With Windsor Pharmaceuticals who just received regulatory approval to sell the same products. Products were ordered for first order. • Third product launch shortly at hand through Bayer Pharmaceuticals who are selling VS-Sense in Europe. They now want Mexico and Latin America which Easton currently has the rights to so that will get finalized and once announced WATCH OUT!. •. Alliance partners agreement has guaranteed revenues stream secured through property. Medical marijuana approval might soon be announced early in October but they already have contracts announced for the Aggregate business which will not start until they receive a response regarding their medical marijuana initiatives for Canada which will have an answer by the end of this month. By the end of the month we should hear some very good news. • iBliss is on board with everything which Easton has indicated they appreciated iBliss's patience as they can see the value with Alliance Group. My friends the big run with new highs is soon here as too many catalysts to ignore. This company will not be undervalued for much longer. Do your own due diligence and speak to the company about getting accurate information. This includes reading their financial statements and press releases very closely . 3 weeks ago, Easton went up by 50% in a week. That will soon be smalltime returns.
